Metabasis Reports Disappointments On Two Pipeline Candidates
This article was originally published in The Pink Sheet Daily
Executive Summary
Phase IIb trial of a type 2 diabetes candidate fails to show efficacy over metformin, and Schering-Plough also returns rights to hepatitis b candidate pradefovir.